News & Press

Saluda Medical Receives U.S. FDA Approval for New CAP24™ Surgical Paddle Lead

CSV Import6/30/2026·06/30/26🌐 USA

Why it matters

The CAP24 paddle lead gives neurosurgeons a new hardware option for closed-loop spinal cord stimulation, extending Saluda's data-driven Evoke platform to more implantation approaches for chronic pain management.

#SCS#Neuromodulation#Chronic Pain#FDA Approved

Want the full NeurotechMag Pro intelligence database?

Access 800+ papers, trials, patents, funding rounds and news items — updated daily.

Start free trial

Already a member? Sign in